News
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback